T1	ANAT 33 41	calostro
#1	AnnotatorNotes T1	C0009413; Colostrum; Body Substance
T2	PROC 847 860	procedimiento
#2	AnnotatorNotes T2	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T3	DISO 72 82	prematuros
#3	AnnotatorNotes T3	C0021294; Infant, Premature; Finding | C0728731; Prematurity of fetus; Finding
T4	CHEM 104 121	inmunoglobulina A
#4	AnnotatorNotes T4	C0020835; immunoglobulin A; Amino Acid, Peptide, or Protein · Immunologic Factor
T5	DISO 182 187	RNMBP
#5	AnnotatorNotes T5	C0745272; INFANT PRETERM VERY LOW BIRTH WEIGHT; Finding
T6	DISO 140 180	recién nacido prematuro de muy bajo peso
#6	AnnotatorNotes T6	C0745272; INFANT PRETERM VERY LOW BIRTH WEIGHT; Finding
T7	ANAT 358 366	calostro
#7	AnnotatorNotes T7	C0009413; Colostrum; Body Substance
T8	CHEM 455 472	inmunoglobulina A
#8	AnnotatorNotes T8	C0020835; immunoglobulin A; Amino Acid, Peptide, or Protein · Immunologic Factor
T9	DISO 1681 1686	RNMBP
#9	AnnotatorNotes T9	C0745272; INFANT PRETERM VERY LOW BIRTH WEIGHT; Finding
T10	ANAT 479 485	sérica
#10	AnnotatorNotes T10	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T11	DISO 489 531	recién nacidos prematuros de muy bajo peso
#11	AnnotatorNotes T11	C0745272; INFANT PRETERM VERY LOW BIRTH WEIGHT; Finding
T12	PROC 601 658	estudio de intervención no aleatorizado con grupo control
#12	AnnotatorNotes T12	C2985410; Nonrandomized; Research Activity + C3274035; Interventional Study; Research Activity + C0007328; Case-Control Studies; Research Activity
T13	ANAT 801 809	calostro
#13	AnnotatorNotes T13	C0009413; Colostrum; Body Substance
T14	CHEM 946 949	IgA
#14	AnnotatorNotes T14	C0020835; immunoglobulin A; Amino Acid, Peptide, or Protein · Immunologic Factor
T15	ANAT 956 962	sangre
#15	AnnotatorNotes T15	C0005767; Blood; Body Substance
T16	PROC 1081 1092	seguimiento
#16	AnnotatorNotes T16	C1522577; Follow up; Health Care Activity | C0420316; Other follow-up; Health Care Activity
T17	CHEM 1107 1110	IgA
#17	AnnotatorNotes T17	C0020835; immunoglobulin A; Amino Acid, Peptide, or Protein · Immunologic Factor
T18	ANAT 1111 1117	sérica
#18	AnnotatorNotes T18	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T19	CHEM 1405 1408	IgA
#19	AnnotatorNotes T19	C0020835; immunoglobulin A; Amino Acid, Peptide, or Protein · Immunologic Factor
T20	ANAT 1409 1415	sérica
#20	AnnotatorNotes T20	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T21	ANAT 1574 1582	calostro
#21	AnnotatorNotes T21	C0009413; Colostrum; Body Substance
T22	ANAT 1625 1645	sistema inmunológico
#22	AnnotatorNotes T22	C0020962; Immune system; Body System | C1305754; Entire immune system; Body System
T23	DISO 1668 1678	prematuros
#23	AnnotatorNotes T23	C0021294; Infant, Premature; Finding | C0728731; Prematurity of fetus; Finding
T24	PROC 1711 1714	IgA
#24	AnnotatorNotes T24	C0202083; Immunoglobulin A measurement; Laboratory Procedure
T25	PROC 15 53	administración de calostro orofaríngeo
T26	PROC 93 121	niveles de inmunoglobulina A
#25	AnnotatorNotes T26	C0202083; Immunoglobulin A measurement; Laboratory Procedure
T27	PROC 340 378	administración de calostro orofaríngeo
T28	PROC 444 485	niveles de inmunoglobulina A (IgA) sérica
#26	AnnotatorNotes T28	C2711348; Measurement of immunoglobulin A in serum specimen; Laboratory Procedure
T29	CHEM 474 477	IgA
#27	AnnotatorNotes T29	C0020835; immunoglobulin A; Amino Acid, Peptide, or Protein · Immunologic Factor
T30	LIVB 687 701	recién nacidos
#28	AnnotatorNotes T30	C0021289; Infant, Newborn; Age Group
T31	PROC 935 962	niveles de IgA en la sangre
#29	AnnotatorNotes T31	C0854061; Blood immunoglobulin A; Laboratory Procedure
T32	PROC 1107 1117	IgA sérica
#30	AnnotatorNotes T32	C2711348; Measurement of immunoglobulin A in serum specimen; Laboratory Procedure
T33	PROC 1181 1193	intervención
#31	AnnotatorNotes T33	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T34	PROC 1394 1415	niveles de IgA sérica
#32	AnnotatorNotes T34	C2711348; Measurement of immunoglobulin A in serum specimen; Laboratory Procedure
T35	PROC 1465 1477	intervención
#33	AnnotatorNotes T35	C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T36	PROC 1556 1594	administración de calostro orofaríngeo
T37	Route 42 53	orofaríngeo
#34	AnnotatorNotes T37	C1522409; Oropharyngeal Route of Drug Administration; Functional Concept
T39	Route 367 378	orofaríngeo
#35	AnnotatorNotes T39	C1522409; Oropharyngeal Route of Drug Administration; Functional Concept
T40	Duration 401 432	los primeros 15 días posnatales
T41	Duration 540 553	el primer mes
T43	LIVB 645 658	grupo control
#36	AnnotatorNotes T43	C0009932; Control Groups; Group
T45	Duration 706 722	≤ 32 + 6 semanas
T46	PHYS 726 735	gestación
#37	AnnotatorNotes T46	C0032961; Pregnancy; Organism Function
T48	LIVB 772 779	sujetos
#38	AnnotatorNotes T48	C0681850; Study Subject; Group
T49	Dose 791 797	0,2 ml
T50	LIVB 816 821	madre
#39	AnnotatorNotes T50	C0026591; Mother (person); Family Group
T51	Frequency 822 830	cada 4 h
T52	Duration 864 881	las primeras 24 h
T53	PHYS 966 976	nacimiento
#40	AnnotatorNotes T53	C0005615; Birth; Organism Function | C1148523; Childbirth; Organism Function
T54	Date 1031 1042	perinatales
#41	AnnotatorNotes T54	C0178795; Perinatal period; Temporal Concept
T55	PHYS 1046 1056	nacimiento
#42	AnnotatorNotes T55	C0005615; Birth; Organism Function | C1148523; Childbirth; Organism Function
T56	LIVB 1172 1193	grupo de intervención
#43	AnnotatorNotes T56	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T61	LIVB 1276 1289	grupo control
#44	AnnotatorNotes T61	C0009932; Control Groups; Group
T66	Duration 1377 1380	mes
T68	LIVB 1456 1477	grupo de intervención
#45	AnnotatorNotes T68	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T69	LIVB 1488 1501	grupo control
#46	AnnotatorNotes T69	C0009932; Control Groups; Group
T71	Route 1583 1594	orofaríngeo
#47	AnnotatorNotes T71	C1522409; Oropharyngeal Route of Drug Administration; Functional Concept
T72	Duration 1718 1721	mes
T73	LIVB 57 82	recién nacidos prematuros
#48	AnnotatorNotes T73	C4048294; Preterm Infant; Age Group
T75	LIVB 140 163	recién nacido prematuro
#49	AnnotatorNotes T75	C4048294; Preterm Infant; Age Group
T78	LIVB 489 514	recién nacidos prematuros
#50	AnnotatorNotes T78	C4048294; Preterm Infant; Age Group
T81	LIVB 1653 1678	recién nacidos prematuros
#51	AnnotatorNotes T81	C4048294; Preterm Infant; Age Group
T74	PHYS 281 288	defensa
#52	AnnotatorNotes T74	C1817756; Immune System Processes; Organ or Tissue Function
T38	Date 896 917	el 15.o día postnatal
T42	Duration 978 1000	3.er, 15.o y 30.o días
T44	PROC 762 766	peso
#53	AnnotatorNotes T44	C2985231; Body Weight Measurement; Diagnostic Procedure
T47	PHYS 1610 1645	desarrollo del sistema inmunológico
#54	AnnotatorNotes T47	C1817972; immune system development; Biologic Function
A1	Population_data T73 Age
A2	Population_data T75 Age
A3	Population_data T78 Age
A4	Population_data T81 Age
A5	Population_data T30 Age
T57	Neg_cue 625 627	no
T58	Quantifier_or_Qualifier 628 640	aleatorizado
A6	Assertion T58 Negated
R1	Negation Arg1:T57 Arg2:T58	
R2	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T58	
T59	Observation 313 320	efectos
A7	Assertion T59 Speculated
#55	AnnotatorNotes T59	C0235735; Unexpected therapeutic effect; Finding (?)
T60	Spec_cue 325 330	pueda
R3	Speculation Arg1:T60 Arg2:T59	
R4	Before Arg1:T27 Arg2:T59	
T62	Spec_cue 1541 1548	sugiere
A8	Assertion T47 Speculated
R5	Speculation Arg1:T62 Arg2:T47	
R6	Before Arg1:T36 Arg2:T47	
R7	Experiences Arg1:T81 Arg2:T47	
R8	Experiences Arg1:T81 Arg2:T23	
R9	Overlap Arg1:T24 Arg2:T72	
R10	Has_Route_or_Mode Arg1:T36 Arg2:T71	
R11	Experiences Arg1:T81 Arg2:T36	
R12	Used_for Arg1:T1 Arg2:T25	
R13	Has_Route_or_Mode Arg1:T25 Arg2:T37	
R14	Experiences Arg1:T73 Arg2:T3	
R15	Experiences Arg1:T73 Arg2:T25	
R16	Experiences Arg1:T73 Arg2:T26	
R17	Experiences Arg1:T75 Arg2:T6	
R18	Experiences Arg1:T75 Arg2:T5	
T63	Observation 192 218	inmunológicamente inmaduro
R19	Experiences Arg1:T75 Arg2:T63	
T64	Observation 241 288	alteración de las barreras naturales de defensa
R21	Experiences Arg1:T75 Arg2:T64	
R22	Used_for Arg1:T7 Arg2:T27	
R23	Has_Route_or_Mode Arg1:T27 Arg2:T39	
R24	Has_Duration_or_Interval Arg1:T27 Arg2:T40	
R25	Location_of Arg1:T10 Arg2:T28	
R26	Experiences Arg1:T78 Arg2:T11	
R27	Experiences Arg1:T78 Arg2:T28	
R28	Experiences Arg1:T78 Arg2:T27	
R29	Experiences Arg1:T78 Arg2:T59	
R32	Overlap Arg1:T28 Arg2:T41	
R33	Has_Duration_or_Interval Arg1:T59 Arg2:T41	
R34	Experiences Arg1:T43 Arg2:T44	
R35	Experiences Arg1:T30 Arg2:T44	
R36	Has_Duration_or_Interval Arg1:T46 Arg2:T45	
T65	Result_or_Value 740 758	menores de 1.500 g
R37	Has_Result_or_Value Arg1:T44 Arg2:T65	
R38	Has_Dose_or_Strength Arg1:T13 Arg2:T49	
R39	Has_Frequency Arg1:T13 Arg2:T51	
R40	Experiences Arg1:T48 Arg2:T13	
R41	Used_for Arg1:T13 Arg2:T2	
R42	After Arg1:T2 Arg2:T52	
R43	Experiences Arg1:T48 Arg2:T2	
R44	Before Arg1:T2 Arg2:T38	
R45	Location_of Arg1:T15 Arg2:T31	
R46	Overlap Arg1:T31 Arg2:T53	
R47	Overlap Arg1:T31 Arg2:T42	
T67	PROC 1010 1030	Se registraron datos
#56	AnnotatorNotes T67	C0010995; Data Collection; Research Activity | C0262727; Research data collection; Research Activity
R48	Overlap Arg1:T67 Arg2:T54	
R49	Overlap Arg1:T67 Arg2:T55	
R50	Overlap Arg1:T67 Arg2:T16	
R51	Location_of Arg1:T18 Arg2:T32	
R52	Experiences Arg1:T56 Arg2:T33	
R53	Experiences Arg1:T56 Arg2:T32	
R54	Experiences Arg1:T61 Arg2:T32	
T70	Observation 1107 1125	IgA sérica aumentó
#57	AnnotatorNotes T70	C0239984; Increased circulating IgA level; Finding (?)
R55	Experiences Arg1:T56 Arg2:T70	
R56	Experiences Arg1:T61 Arg2:T70	
R57	Overlap Arg1:T34 Arg2:T66	
R58	Location_of Arg1:T20 Arg2:T34	
R59	Experiences Arg1:T68 Arg2:T34	
R60	Experiences Arg1:T68 Arg2:T35	
R61	Experiences Arg1:T69 Arg2:T34	
R62	Before Arg1:T33 Arg2:T70	
R64	Used_for Arg1:T21 Arg2:T36	
T76	Observation 1700 1714	aumento de IgA
#58	AnnotatorNotes T76	C0239984; Increased circulating IgA level; Finding (?)
R65	Experiences Arg1:T81 Arg2:T76	
R66	Experiences Arg1:T81 Arg2:T24	
R67	Location_of Arg1:T22 Arg2:T47	
R68	Before Arg1:T36 Arg2:T76	
R69	Overlap Arg1:T47 Arg2:T76	
R70	Experiences Arg1:T81 Arg2:T9	
T77	Observation 1 8	Efectos
#59	AnnotatorNotes T77	C1518681; Outcome of Therapy; Finding (?)
R71	Causes Arg1:T25 Arg2:T77	
R72	Experiences Arg1:T73 Arg2:T77	
A9	Experiencer T73 Patient
A10	Experiencer T75 Patient
A11	Experiencer T78 Patient
A12	Experiencer T43 Patient
A13	Experiencer T30 Patient
A14	Experiencer T48 Patient
A15	Experiencer T50 Family_member
A16	Experiencer T56 Patient
A17	Experiencer T61 Patient
A18	Experiencer T68 Patient
A19	Experiencer T69 Patient
A20	Experiencer T81 Patient
R20	Has_Result_or_Value Arg1:T24 Arg2:T76	
R30	Has_Result_or_Value Arg1:T32 Arg2:T70	
